Literature DB >> 6816331

Erythropoietin and renal function in sickle-cell disease.

A G Morgan, C A Gruber, G R Serjeant.   

Abstract

The relation between haemoglobin concentration, creatinine clearance, and the serum concentration of erythropoiesis-stimulating factor were assessed in 31 patients with homozygous sickle-cell disease. Haemoglobin concentrations fell significantly with decreasing creatinine clearance (r = 0.58, p less than 0.001) and were positively correlated with the concentration of erythropoiesis-stimulating factor (r = 0.65, p less than 0.001). These observations suggest that erythropoietin concentration is the factor limiting production of red cells in sickle-cell disease with renal insufficiency and have implications for treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6816331      PMCID: PMC1500701          DOI: 10.1136/bmj.285.6356.1686

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

1.  Studies on a radioimmunoassay for human erythopoietin.

Authors:  J J Lertora; P A Dargon; A B Rege; J W Fisher
Journal:  J Lab Clin Med       Date:  1975-07

2.  Erythropoietin excretion in bone marrow failure and hemolytic anemia.

Authors:  R Alexanian
Journal:  J Lab Clin Med       Date:  1973-09

3.  Bioassay of erythropoietin using foetal mouse liver cells.

Authors:  D F Wardle; J S Malpas; P F Wrigley
Journal:  Br J Haematol       Date:  1973-01       Impact factor: 6.998

4.  Erythropoietin in acute erythroblastopenia of sickle cell anemia.

Authors:  A Okçuoğlu
Journal:  Turk J Pediatr       Date:  1964-10       Impact factor: 0.552

5.  Production, utilization and excretion of erythropoietin. I. Chronic anemias. II. Aplastic crisis. 3. Erythropoietic effects of normal plasma.

Authors:  D Hammond; N Shore; N Movassaghi
Journal:  Ann N Y Acad Sci       Date:  1968-03-29       Impact factor: 5.691

6.  Erythropoiesis in chronic renal disease.

Authors:  S Zucker; R M Lysik; G Mohammad
Journal:  J Lab Clin Med       Date:  1976-10

7.  Erythropoietin levels in uremic nephric and anephric patients.

Authors:  J Caro; S Brown; O Miller; T Murray; A J Erslev
Journal:  J Lab Clin Med       Date:  1979-03

8.  Erythropoiesis in sickle cell anaemia during acute infection and crisis.

Authors:  T B Haddy; J M Lusher; S Hendricks; B K Trosko
Journal:  Scand J Haematol       Date:  1979-04-04

9.  Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function.

Authors:  H W Radtke; A Claussner; P M Erbes; E H Scheuermann; W Schoeppe; K M Koch
Journal:  Blood       Date:  1979-10       Impact factor: 22.113

10.  Serum erythropoietin (EST) titers in anemia.

Authors:  G de Klerk; P C Rosengarten; R J Vet; R Goudsmit
Journal:  Blood       Date:  1981-12       Impact factor: 22.113

View more
  4 in total

Review 1.  End stage renal disease in sickle cell disease: future directions.

Authors:  C R Tomson
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401

2.  Normal haemoglobin electrophoretic pattern in a patient with sickle cell disease and end stage renal failure.

Authors:  J C Marsh; L R Baker; G W Marsh
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

3.  Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review.

Authors:  Jane A Little; Vicki R McGowan; Gregory J Kato; Kristine S Partovi; Jordan J Feld; Irina Maric; Sabrina Martyr; James G Taylor; Roberto F Machado; Theo Heller; Oswaldo Castro; Mark T Gladwin
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

4.  Erythropoiesis-stimulating agents in sickle cell anaemia.

Authors:  Jin Han; Jifang Zhou; Vinod Kondragunta; Xu Zhang; Robert E Molokie; Michel Gowhari; Johara Hassan; Shivi Jain; Gregory S Calip; Victor R Gordeuk; Santosh L Saraf
Journal:  Br J Haematol       Date:  2017-07-27       Impact factor: 6.998

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.